Poster presentations
Open the list of posters
1
November 7 (Thursday) evening
2
Opening ceremony
3
4
14.00- Registration
5
6
18.00-18.15 Welcome and introduction
7
Ágoston Szél
8
Rector of Semmelweis University
9
10
18.15-18.45 Semmelweis Award 2013 – Laudation and video presentation
11
Award recipient:
12
György Oláh (Los Angeles, USA)
13
14
18.45-19.30 Opening lecture
15
András Falus (Budapest, Hungary)
16
“Me, myself and us”: Microbiota ecosystems in inflammation regulation
17
18
19.30-21.30 Welcome reception
19
20
November 8 (Friday) morning
21
Molecular mechanisms in inflammatory diseases
22
Chairs: László Kovács (Szeged, Hungary),

Andrew Luster (Boston, USA)

23
24
8.30-9.00 Steffen Gay (Zürich, Switzerland)
25
Epigenetic regulation in rheumatic diseases
26
27
9.00-9.30 Paul Winyard (Exeter, UK)
28
Oxidative stress and biomarkers in human inflammatory joint disease
29
30
9.30-9.45 Sofia de Oliveira (Murcia, Spain)
31
ATP and Calcium modulate the inflammatory response via Duox 1 activation and hydrogen peroxide release
32
33
9.45-10.00 Chaekyun Kim (Incheon, Korea)
34
The role of NADPH oxidase-derived taurine chloramine in collagen-induced arthritis
35
36
10.00-10.15 Gábor Zahuczky (Debrecen, Hungary)
37
Distinct gene panels predict response to infliximab therapy from peripheral blood in rheumatoid arthritis and Crohn’s disease
38
39
10.15-10.30 Biljana Smiljanovic (Berlin, Germany)
40
From transcriptome data to protein biomarkers in RA: joint compartment and monocytes outperform serum as sample material for diagnosis
41
42
10.30-11.00 Coffee break
43
44
11.00-11.45 Keynote lecture
45
Ravinder Maini (London, UK)
46
Revolutionizing therapy of rheumatoid arthritis by TNF blockers: as it happened
47
48
11.45-12.15 David Pisetsky (Durham, USA)
49
The role of microparticles in the pathogenesis of inflammatory disease
50
51
12.15-12.35 Edit Buzás (Budapest, Hungary)
52
Extracellular vesicles in inflammation
53
54
12.35-12.50 Zsuzsa Szondy (Debrecen, Hungary)
55
Transglutaminase 2 limits gout arthritis by inhibiting both the monosodium urate-induced proinflammatory response and the removal of apoptotic neutrophils by macrophages at the inflammation site
56
57
12.50-13.00 Group photo
58
59
13.00-14.00 Lunch
60
61
November 8 (Friday) afternoon
62
Interaction of different cell types in inflammation
63
Chairs: László Czirják (Pécs, Hungary),

Lionel Ivashkiv (New York, USA)

64
65
14.00-14.30 Hiroshi Takayanagi (Tokyo, Japan)
66
Cell communication in osteoimmunology –

crosstalk between osteocytes and osteoclasts

67
68
14.30-14.50 Péter Lakatos (Budapest, Hungary)
69
Molecular targets in pathological bone resorption
70
71
14.50-15.05 Dávid Győri (Budapest, Hungary)
72
The phosphoinositide-3-kinase isoform PI3Kβ regulates osteoclast-mediated bone resorption
73
74
15.05-15.20 Vasileia Ismini Alexaki (Dresden, Germany)
75
NGF: a modulator of microglia-mediated inflammation
76
77
15.20-15.35 Bálint Botz (Pécs, Hungary)
78
Divergent roles of PACAP in nociception and inflammation in the serum transfer arthritis model of the mouse
79
80
15.35-16.00 Coffee break
81
82
16.00-16.30 Andrew Luster (Boston, USA)
83
Neutrophil activation and recruitment in inflammatory arthritis
84
85
16.30-17.00 Oliver Distler (Zürich, Switzerland)
86
microRNAs in the pathogenesis of fibrosis
87
88
17.00-17.15 Ádám Dénes (Budapest, Hungary)
89
Infection-induced systemic inflammatory mechanisms mediate inflammation and injury in the brain after cerebral ischaemia
90
91
17.15-17.30 Anna Buday (Budapest, Hungary)
92
Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice
93
94
17.30-17.50 Pál Géher (Budapest, Hungary)
95
Understanding spondylarthritis: from bedside to the bench (sponsored by MSD)
96
97
18.00-21.00 Poster viewing and buffet dinner
98
99
November 9 (Saturday) morning
100
Tyrosine kinases in inflammatory diseases
101
Chairs: Gyula Poór (Budapest, Hungary),

Hiroshi Takayanagi (Tokyo, Japan)

102
103
8.30-8.50 Zoltán Szekanecz (Debrecen, Hungary)
104
Unmet therapeutic needs in clinical rheumatology
105
106
8.50-9.20 Emese Kiss (Budapest, Hungary)
107
Targeting JAK kinases in human autoimmune diseases (sponsored by Pfizer)
108
109
9.20-9.50 Barbara Walzog (Munich, Germany)
110
The Syk tyrosine kinase pathway in neutrophil migration
111
112
9.50-10.05 Réka Kugyelka (Pécs, Hungary)
113
The effect of ZAP-70 deficiency upon the histological composition of primary- and secondary lymphoid organs in mice
114
115
10.05-10.20 Zoltán Pós (Budapest, Hungary)
116
Genomic scale analysis of the genetic background of interferon alpha responsiveness
117
118
10.20-11.00 Coffee break
119
120
11.00-11.30 Clifford Lowell (San Francisco, USA)
121
Negative regulation of autoimmunity and inflammation by the Lyn tyrosine kinase
122
123
11.30-11.45 Tamás Németh (Budapest, Hungary)
124
CARD9 mediates autoantibody-induced autoimmune diseases by linking the Syk tyrosine kinase to cytokine production
125
126
11.45-12.00 Attila Mócsai (Budapest, Hungary)
127
Syk as a therapeutic target in rheumatology: pros, cons, myths and unknowns
128
129
12.00-12.15 Tamas Oravecz (The Woodlands, USA)
130
Genetic and pharmacologic inhibition of Mst1 alters T-cell function and protects against inflammation and autoimmunity
131
132
12.15-12.35 László Kovács (Szeged, Hungary)
133
Methotrexate –old drug, new hopes (sponsored by Sager Pharma)
134
135
12.35-13.00 Poster award ceremony
136
137
13.00-14.00 Lunch
138
139
November 9 (Saturday) afternoon
140
Other receptors and signaling in inflammation
141
Chairs: David Pisetsky (New York, USA)
142
Erzsébet Ligeti (Budapest, Hungary)
143
144
14.00-14.30 Lars Klareskog (Stockholm, Sweden)
145
Genetic and environmental factors determining susceptibility to rheumatoid arthritis
146
147
14.30-15.00 Thomas Pap (Münster, Germany)
148
Intracellular signaling in rheumatoid arthritis synovial fibroblast
149
150
15.00-15.15 Szilvia Benkő (Debrecen, Hungary)
151
Molecular differences of the NLRP3 inflammasome-mediated IL-1β production in LPS- activated human monocyte-derived macrophage subtypes
152
153
15.15-15.30 Timea Csák (Worcester, USA)
154
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in non-alcoholic steatohepatitis
155
156
15.30-16.00 Coffee break
157
158
16.00-16.30 Lionel Ivashkiv (New York, USA)
159
Regulation of Inflammatory cytokine production by signaling and epigenetic mechanisms
160
161
16.30-16.50 György Nagy (Budapest, Hungary)
162
The regulation of CD3ζ-chain expression on human T

lymphocytes

163
164
16.50-17.10 Tamás Bíró (Debrecen, Hungary)
165
Cannabinoid signaling in cutaneous inflammation
166
167
17.10-17.25 Attila Bácsi (Debrecen, Hungary)
168
TLR ligands up-regulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner
169
170
17.25-17.40 Nandor Than (Grosse Pointe Woods, USA)
171
Novel biomarkers and pathologic pathways of preeclampsia discovered by high-dimensional and systems biology
172
173
17.40-18.00 Concluding remarks and closing of the conference
174
175
19.00 Dinner for the invited speakers at the Hungarian Academy of Sciences